Human enterotoxigenic Escherichia coli (ETEC) infections elicit antibodies that broadly neutralize mucinases of pathogenic Escherichia coli and Shigella
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2614012123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von David P Buckley und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Missouri Columbia, Columbia, MO 65201. Hauptthemen laut MEDLINE: Enterotoxigenic Escherichia coli, Escherichia coli Proteins, Escherichia coli Infections, Mucin-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, U.S. Department of Veterans Affairs (VA), HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).
Abstract (Originalsprache)
Enterotoxigenic Escherichia coli (ETEC) and Shigella are the most common bacterial diarrheal pathogens among young children of low-middle income regions. Enteric pathogens must overcome formidable host defenses, including the protective barrier formed by intestinal mucus. ETEC produce a virulence protein called EatA, a member of the Serine Protease Autotransporter of the Enterobacteriae (SPATE) family, where the secreted passenger domain (EatA p ) specifically degrades MUC2, the major mucus secreted by goblet cells of the human intestine. Notably, some Shigella spp., as well as other diarrheagenic E. coli pathovars, secrete homologues of EatA known as SepA, and Pic. Here, we demonstrate that EatA, SepA, and Pic are functionally redundant MUC2 mucinases and that recombinant monoclonal antibodies (mAbs) derived from plasmablasts of ETEC-infected humans can inhibit MUC2 degradation by all three proteases. We present cryo-EM structures of EatA and the related SPATE proteins, SepA, and Pic, complexed to fragment antigen-binding portions of these mAbs to demonstrate that those targeting a core β-helix epitope shared by all three SPATE molecules broadly neutralize the capacity to degrade MUC2. These mAbs effectively prevent MUC2 degradation by each SPATE as well as mucus penetration by ETEC, Shigella flexneri , and Pic-producing enteroaggregative E. coli (EAEC). We anticipate that these studies could facilitate rational design of vaccines that broadly protect against major enteric pathogens by targeting a shared virulence feature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Missouri Columbia, Columbia, MO 65201.
- Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
- Mucosal Immunology and Vaccinology Unit, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka 1000, Bangladesh.
- Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine, Saint Louis, MO 63110.
- Military Relevant Bacterial Diseases Department, Naval Medical Research Command, Silver Spring, MD 20910.
- Translational and Clinical Research Department, Naval Medical Research Command, Silver Spring, MD 20910.
ORCID-Profile: David P Buckley, Jackson Turner, Alaullah Sheikh, Tafiqur R Bhuiyan, Sergio Trillo-Muyo, Brendan Dolan, Sjoerd van der Post, James M Fleckenstein
Förderung
- NIAID NIH HHS
- U.S. Department of Veterans Affairs (VA)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
Zitieren
APA
Buckley, D. P., Akhtar, M., Thapa, M., Schmitz, A., Turner, J., Vickers, T. J., Khatoon, N., Kaisar, M. H., Coggin, J. A., Ganguli, D., Sheikh, A., Laird, R. M., Poly, F., Porter, C. K., Ruiz-Perez, F., Miller, M. J., Chowdhury, F., Bhuiyan, T. R., Qadri, F., …, & Fleckenstein, J. M. (2026). Human enterotoxigenic Escherichia coli (ETEC) infections elicit antibodies that broadly neutralize mucinases of pathogenic Escherichia coli and Shigella. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2614012123
Vancouver
Buckley DP, Akhtar M, Thapa M, Schmitz A, Turner J, Vickers TJ, et al. Human enterotoxigenic Escherichia coli (ETEC) infections elicit antibodies that broadly neutralize mucinases of pathogenic Escherichia coli and Shigella. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2614012123
BibTeX
@article{Buckley2026,
author = {Buckley, David P and Akhtar, Marjahan and Thapa, Mahima and Schmitz, Aaron and Turner, Jackson and Vickers, Tim J and Khatoon, Nazia and Kaisar, M Hasanul and Coggin, Jonathan A and Ganguli, Debayan and Sheikh, Alaullah and Laird, Renee M and Poly, Frédéric and Porter, Chad K and Ruiz-Perez, Fernando and Miller, Mark J and Chowdhury, Fahima and Bhuiyan, Tafiqur R and Qadri, Firdausi and Trillo-Muyo, Sergio and Dolan, Brendan and van der Post, Sjoerd and Ellebedy, Ali and Berndsen, Zachary T and Fleckenstein, James M},
title = {Human enterotoxigenic Escherichia coli (ETEC) infections elicit antibodies that broadly neutralize mucinases of pathogenic Escherichia coli and Shigella},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2614012123}
}
EUVIMED